Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Toronto, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Toronto, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University of Toronto, Medical Devices Deals, 2011 to YTD 2017 10
University of Toronto, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University of Toronto, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Celgene Partners with Recombinant Antibody Network 13
Edge Therapeutics Enters into Research and Discovery Agreement with St. Michael’s Hospital 15
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 16
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 17
Sanofi-aventis Enters Into Research Agreement With Sunnybrook Health Sciences Center 18
Licensing Agreements 19
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 19
InDanio Biosciences Receives Intellectual Property Rights from University of Toronto 20
Kolltan Pharma Enters Into Licensing Agreement With University of Toronto For Anti-KIT Antibodies And Related IP 21
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 22
Asset Transactions 23
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 23
Regen BioPharma to Acquire Cancer Stem Cell Intellectual Property from University of Toronto 24
University of Toronto – Key Competitors 25
University of Toronto – Key Employees 26
University of Toronto – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Affiliate 27
Joint Venture 28
Recent Developments 29
Strategy And Business Planning 29
Oct 11, 2017: University of Toronto and Medicxi launch Janpix to Advance Dual Impact Cancer Therapies 29
Government and Public Interest 30
Nov 06, 2017: Scientists discover potential treatment to stop glaucoma in its tracks 30
Oct 13, 2017: Neurotechnological innovation and organ-on-a-chip engineering centres receive more than $10 million in new funding 32
Mar 20, 2017: Canadian collaboration to accelerate development of cancer treatments 33
Jul 21, 2016: New Method for Identifying Proteins Should have a Major Impact on the Development of New Biologics 35
Jun 20, 2016: Breast Cancer Cells Use Newfound Pathway to Survive Low Oxygen Levels in Tumors 36
Jun 07, 2016: Six new drug discovery acceleration projects supported by CQDM and Ontario Centres of Excellence 38
Mar 17, 2016: Stem cell therapy reverses age-related osteoporosis in mice 40
Feb 18, 2016: Engineering nanoparticles that can change their shape to deliver cancer drugs to tumours 41
Jan 07, 2016: Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario 42
Other Significant Developments 43
Sep 19, 2017: Google Glass app helps autistic children with social interactions 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
University of Toronto, Pharmaceuticals & Healthcare, Key Facts 2
University of Toronto, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Toronto, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Toronto, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Toronto, Deals By Therapy Area, 2011 to YTD 2017 9
University of Toronto, Medical Devices Deals, 2011 to YTD 2017 10
University of Toronto, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Celgene Partners with Recombinant Antibody Network 13
Edge Therapeutics Enters into Research and Discovery Agreement with St. Michael’s Hospital 15
Blueline Bioscience Forms Joint Venture with University of Toronto and University Health Network 16
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 17
Sanofi-aventis Enters Into Research Agreement With Sunnybrook Health Sciences Center 18
Advanced Proteome Therapeutics Enters into Option Agreement with Toronto Recombinant Antibody Centre 19
InDanio Biosciences Receives Intellectual Property Rights from University of Toronto 20
Kolltan Pharma Enters Into Licensing Agreement With University of Toronto For Anti-KIT Antibodies And Related IP 21
Stem Cell Therapeutics Enters Into Option For Licensing Agreement With University Of Toronto 22
NovaDigm Therapeutics Acquires Rights to Beta-Mannan Trisaccharide Conjugate from University of Alberta, Louisiana State University School of Medicine and University of Toronto 23
Regen BioPharma to Acquire Cancer Stem Cell Intellectual Property from University of Toronto 24
University of Toronto, Key Competitors 25
University of Toronto, Key Employees 26
University of Toronto, Other Locations 27
University of Toronto, Subsidiaries 27
University of Toronto, Affiliate 27
University of Toronto, Joint Venture 28